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1. Introduction 
Nowadays, steady progress like in endovascular, microsurgical, neuroendoscopic fields, 
affect deeply neurosurgergical field, too. But in spite of arising so many innovations, 
average survival time in glioma is a year and five  year survival rate is 8%. These results 
have not slightly changed for 30 years.(*1) 
For us to continue research glioma in future, our purpose discloses what we should be going 
to do for improve prognosis and needs to analyze  data about tumor cells in the various 
views. In our laboratory, we research brain tumor with flow cytometory. In this chapter, we 
describe how to analyze the mechanism of various antineoplastic agents  for tumor cells 
centered glioma and research results with flow cytometry. 
2. Chemotherapy for central nerves system 
There is Blood Brain Barrier, as you know, in central nervous system like a brain and a 
spinal cord. We can easy to understand the Blood Brain Barrier referred to fig 1(*2). Arteries 
and veins from subarachnoid space feed the brain after perforating vertically brain pia 
matter and extending into brain substance. In extending into brain substance, micro 
perivascular space is formed around vessels in brain substance. It is for us to observe a 
section of vessels in brain substance (Fig1-2). Vascular endothelium cells adhered to 
basement membrane form the structure like a tube with tight junction constituted by 
astrocyte and pericyte adhered outside of basement membrane. This structure formed the 
group of cells around basement membrane and tight junction between each endothelium 
around vessels is, so to speak, the Blood Brain Barrier.  
The Blood Brain Barrier is hard to absorb aqueous solution. So This is the difference central 
nervous system from body except it. This property has been the limitation for developing 
chemotherapeutic drugs. According to same above reasons, chemotherapeutic drugs for 
glioma also were limited. But, recently, it has produced starting from ACNU, BCNU, 
CCNU, MCNU, bleomycin , IFN etc, via PCZ, VCR, to TMZ approved. Especially TMZ has 
been a standard drugs for glioma in the world. Though it gradually has progressed, 
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variation for combination therapy for glioma has increased too. In this time, we analyzed 
these chemotherapeutic drugs with FCM, LSC as below. 
 
 
 
Abbreviation: A: Arachnoid membrane, SAS: Subarachnoid space, PAS: Periarterial space, PVS: 
Perivenous space, PF: Perforater foramen, CAPS: Capillary artery perispace 
Fig. 1-1. Shows blood brain barrier. 
 
 
 
Fig. 1-2. Reveal tomography around of micro vessels in the brain. 
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2.1 Prostaglandin J2α(PGJ2α) 
PGJ2͉ is  one of eicosanoid producing in the body. In the beginning of 1980, it cleared up 
that PGD2 was produced after dehydration need to no enzyme. From the late of 1980 to the 
beginning of 1990, it was reported the very effective inhibition of tumor cells and viruses. So 
we expect to have thought of one of new antineoplasitc agent and antiviral drug. But it 
doesn’t attains to apply clinically the glioma therapy, because it is unstable in the body. (*3) 
2.2 Interferon (IFN) 
IFN belongs to glycoprotein family. IFN has been reported it has direct effect for inhibition 
tumor growth, indirect effect with immune system and  the synergy effect with other 
antineoplastic agents(*4). Though IFN has subtypes ͉〜͋, as shown our experimental 
result, IFN͊ is the most effective for glioma(*5). But direct tumor suppression effect about 
IFN is only 18%. In the reports until now, IFN usually has effects combined with other 
antineoplastic agents. The famous report  as for IFN combined with other drugs is about 
IAR(IFN͊+ACNU+Radiation) therapy.  Median survival time about only radiation 
therapy, radiation+ACNU and IAR therapy were each 15.2 months, 19.7 months and 25.3 
months. Initial response rate about radiation +ACNU, IAR therapy were each 35.7%, 60.5%. 
As this result, IAR therapy showed clearly better result than the other (level 4 evidence) 
(*28). Response rate in recent report about IAR therapy is 33%(*29). 
2.3 ACNU 
ACNU is the drug belonging to nitrosourea. This drug easily can pass through BBB. So this was 
standard drug against glioma until TMZ appeared. Though BCNU, CCNU, MCNU is 
developed in the West, ACNU is developed and used in Japan. As for metaanalysis, ACNU 
extended survival time to about one or two year and survival rate increased 6-10% and Median 
survival time extended to about two months. But this results were unsatisfied with us (*6,7). 
2.4 CDDP, CBDCA 
Cisplatin isn’t general therapeutic drug against glioma.  
Rosenberg et al reported it in 1965(*8). CDDP is one of the antineoplastic agent had very 
wide spectrum for various solid tumors. On the other hand, CDDP has high percentage of 
side effect like a toxicity of kidney, the digestive system and auditory system. Carboplatin 
(CBDCA) induced from CDDP was developed in order to reduce the toxicity CBDCA is 
platinum antineoplastic agent in second generation and was developed in England by 
Harrap. Though CBDCA has less antineoplastic effect than CDDP, CBDCA reduces clearly 
side effect like the toxicity for kidney, the digestive system and auditory system(*9). 
2.5 As2O3 (Arsenic trioxide) 
As2O3, which is originally used to treat acute promyelocytic leukemia (APL) since the early 
1970s at Harbin Medical University in China, has drawn attention to treat solid tumors 
including gliomas. As2O3 enhanced radiation response and increase cure rate of glioma 
patients.Mechanisms that might explain the anti-tumor cytotoxicity of As2O3 include its 
ability to induce cellular differentiation, tumor apoptosis, the degradation of specific APL 
transcripts, and inhibition of tumor cell growth by modulating redox balance and/or 
mitochondrial membrane potential.(*24) 
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2.6 Temozolomide (TMZ) 
Temozolomide belongs to the second generation of alkylating agents, and it can be orally. 
This drug has become a standard antineoplastic agent against malignant glioma. The 
effectiveness of this drug has been verified with much evidence. From 1995 to 1997, Yung 
et al. studied the first endpoint of 6 months without tumor progression in cases of 
recurrent anaplastic astrocytoma after addition of 200mg/m2 TMZ during the first 5 days. 
They analyzed about 111 of 162 anaplastic astrocytoma or anaplastic oligodendrocytoma 
cases diagnosed in their pathology center. As a result of these analyses, over all response 
rate (RR) is 66%; for anaplastic astrocytoma, RR is 62%. The complete response rate is 6% 
and the partial response rate is 28%. At present, relatively good outcomes are ensured and 
have been accumulated in phase studies such as those by the RTOG Group. One of the 
representative phase Ⅲ study is the research that ,so to speak, Stupp regimentation was 
added against cohort of 573 cases caught initially GBM by EORTC (European 
Organization for Research and Treatment of Cancer) and NCIC(national cancer institute 
of Canada). In summary, induction therapy is GBM after tumor resection is irradiated 
60Gy and given TMZ (75mg/m2/day) for 6 week. Maintenance therapy is they gave 6 
courses, when one course is TMZ (150〜200mg/m2/day) for 5 days on and 23 days off. In 
the result from this comparison only irradiation with this regimentation, MST (median 
survival time) is 14.6 months in 247 cases administrated TMZ and irradiated, 12.1 months 
in 286 cases only irradiated. 2 year’s survival rate is 26.5% in TMZ group, 10.4% in 
irradiated group. Hazard ratio for death is 38% statistically dominant decrease. In spite of 
excellent result like these, incidence of blood toxicity was only 7%.TMZ prized a level Ⅰ
evidence. 
As above, we used flow cytometer and laser cytometer for tools of analysis the drugs for 
pharmacological mechanism already known on the basis of cell kinetics.  
3. History of flow cytometry (Fig2) and laser cytometry 
Flow cytometer was developed for cancer research in Los Alamos institute in 1959, 
simultaneously, for immune system research in Stanford University. Then, various flow 
cytometer are developed as fig2. Recently,  a serious of FACS made in BD corporation and 
Epix made in Coulter company and so on are familiarized. These developments caused we 
can measure amount of various kinds of ingredients like intracellular DNA and of protein, 
can easy to analyze cell cycle too. In addition, it could see, measure amount of antigens on 
cell surface, major progress with immunology field.   
On the other hand, it had developed image cytometry of analyses about cell figures and 
so on. In 1976, Kawamoto in our institution started the measure intracellular DNA of 
brain tumors, in his being in Monte Fiore Hospital in New York. In 1976, he used with the 
prototype of Fluorograph (Fig3-1), which could measure amount of DNA and its 
histogram, not analyze cell cycles. In 2011, we use, in our institution, FACS Calivur (Fig3-
2), which can analyze simultaneously and automatically histogram, cell cycle, DNA index 
(DI) calculate. In 1991, Kamentsky et al invented Laser Scannning Cytometer(LSC) which 
was the machine having dual character of FCM and image cytometory. LSC can analyze 
automatically amount of DNA and grasp cell figures, after put above the slide prepared 
for a microscope.  
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Fig. 2. History of Flow Cytometry 
 
 
 
 
Fig. 3-1. Prototype of Fluorograph could measure amount of DNA and its histogram, not 
analyze cell cycles (in1976, Monte Fiore Hospital, New York). 
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Fig. 3-2. FACS Calivur in our institution can analyze simultaneously and automatically 
histogram, cell cycle, DNA index (DI) calculated . 
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4. The principle of flowcytometry (Fig4) 
Isolated cell stained with fluorescent pigment dropped from the nozzle. After laser hit each 
cells, it can identify fluorescence dividing into two directions. These fluorescences are 
frontal scatter fluorescence meaning cell size (figure) and lateral scatter fluorescence 
meaning biological property (=relative amount of DNA). Sensors on each direction translate 
these intensities into electric signals depending on amount of DNA, and conduct electric 
circuit (*10). We can analysis passing these signals from 1000 to 5000 cells per second with 
computer. More advanced machine can sort cells through making dropped cells plus or 
minus charge, so to speak, cell sorting (*11,12). Because these machines are delicate, we have 
to adjust repeatedly for reliable datum.  Mainly, these adjustments include flow system, the 
axis of laser. It is important to line up stable laser and water pressure for continue to flow 
isolated cells with regular speeds and orderly from the nozzle. As it repeats the adjustments 
on two or three times with, for example, micro beads, calculates coefficient of variation: CV 
of histogram. In this time, CV with micro beads hopes to be less than 2%. About how to 
adjust in detail, you had better refer to texts and papers (*13,14) 
 
 
Fig. 4. Figure reveals principle of flow cytometory. Isolated cell droped from the nozzle. 
Laser hit each cells. We can analysis passing this laser from 1000 to 5000 cells. More 
advanced machine can sort cells through making dropped cells plus or minus charge. This 
technique can choose cells we can point out free. 
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5. About scattergram (dotgram) 
The data analyzed with flowcytometer good adjusted reveals a scattergram (dotgram) 
like fig 5. Scattergram (dotgram) is consist of x axis set frontal scatter concentration of 
fluorescence and y axis set lateral scatter concentration of fluorescence, is the 
aggregation result from plotting on the basis of each value. Because this aggregation 
includes debris of cells and unnecessary cells, we need to narrow moreover aiming cells. 
What we do to narrow aiming cells is called gating procedure. Gate is the procedure sort 
a aiming group of cells on the basis of wavelength of beam, from whole group of cells. 
Fig 5 reveals dotgram consisted of X axis set 7-AAD used in measuring amount of DNA 
and Y axis set BrdU used in measuring amount of cells in S phase. Revealing concretely 
with Fig 5, the procedure of gating is surrounding square each group of cells. If it sets up 
gating on same condition, you can measure the percentage of any cell groups in whole of 
objective group (In fig.5, you can measure how percentage of each cell in each cell cycle). 
In addition, if you stain cells with monoclonal antigen with FITC (BrdU with FITC in 
fig5), can response differentially antigen on cell surface, you can measure quickly and 
objectively not only whether antigen stained with fluorescence or not, but also measure 
that densities. 
 
 
Fig. 5. This is the dotgram consisted of X axis set 7-AAD and Y axis set BrdU with FITC. 
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6. About histogram 
Various kinds of fluorescence stain are used in measuring amount of nuclear DNA. It is 
hoped that these amount of fluorescence pigment in linear proportion to amount of DNA. In 
our institution, we use PI (Propidum iodide), 7-AAD (Actinomycin D). As s result of 
measure amount of DNA depending on amount of fluorescence pigment, it reveals DNA 
histogram. Generally, there are G0G1 phase cells having DNA amount of 2C, G2M phase 
cells having DNA amount of 4C and S (=synthesis) phase cells between G0G1 and G2M 
phase. Because in S phase the reason of overlap a group of cells in early S phase with a 
group of cells in G0G1 phase and the reason of overlap a group of cells in late S phase with a 
group of G2M phase, we have difficulty in identifying a group cells in S phase. Various 
mathematical models for calculate each division of S, G0G1, S, G2M on cell cycles, were 
reported. For example, Baisch.H et al(*15), Bariogie B et al(*19), Fried et al(*17,18) were 
reported. In this time, we adopted three-division method (Kawamoto et al) (*16) (Fig6). 
 
 
First peak, G0G1 phase; second peak G2M phase; between two peaks, S phase 
Fig. 6. The three-division histogram method (Kawamoto et al.). 
7. Clinical material and method 
We used the target cells as follow: human glioma cell lines like U373, U251, U87MG, KMU100, 
rat glioma cell lines like 9-LMG, C6 and KB cell line (nasopharyngeal carcinoma. Depending 
on each experiment, we added each cell line to medium concentration dose near ED50 
(effective dose 50%) and high concentration dose more than ED 50. ED50 was decided on the 
basis of result from basic experiment like phase Ⅰ study. Cell killing effect depending on 
concentration of dose was assessed with cell count depending on process of times and days. 
Simultaneously, we analyzed the histograms with FCM (or LSC) depending on process of 
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days. When we make the specimen for FCM, we can easy to understand in sight through 
sometimes using double staining (BrdU, PI, 7AAD etc.) method depending on process of days. 
Drugs our analyses histogram in this chapter are ACNU, IFN, PGJ2͉, DCCP, A2O3, TMZ. 
7.1 Culture method 
The established cell lines were subjected to monolayer culture in minimum essential 
medium (MEM) and dMEM(Dulbecco’s modified Eagle’s medium)(Gibco:high glucouse 
with L-glutamine with pyridoxine hydrochloride without sodium pyruvate or sodium 
bicarbonate) supplemented with 10% fetal bovine serum(FBS) in a 5% CO2 incubator. 
7.2 How to make specimen for FCM 
A single suspended cell according to method our draw above was fixed by 70% ethanol. 
After it was made reaction of 0.5% RNAse treatment under 37℃ for 30 minutes, 7AAD or PI 
staining treated cells  went into FCM owing to measure amount of DNA. Flow cytometers 
we used were FACStar and FACS Calivur supported by Becton Dickinson (BD) Corporation. 
For example, FACStar’s laser has wavelength of 488nm, wave strength of 200-500mW and 
long pass filter of 520nm. 
7.3 Double staining method 
For example, in the case that you want to ensure specifically S phase cell, you make reaction 
monoclonal antibody to BrdU with IgG labeled FITC. Everyone has understood DNA uptake 
BrdU (Bromodeoxyuridine) as thymidine (*20). After monoclonal antibody ensured BrdU 
which was developed by Gratzner et al (*21) in 1982, we can analyze cell growth with BrdU. 
Though BrdU is taken into intranuclear DNA in synthesis (S) phase, we can identify cells taken 
anti BrdU antibody by stain after short time treatment. If Z axis are set the density of dots in 
dotgram in addition to X axis set PI or 7AAD and Y axis set BrdU, we can get 3D expression of 
histogram. 3D histogram makes us easy to sight cell distribution in S phase (fig7). 
 
 
Fig. 7. Example of exchange 2D (left graph) for 3D expression (right graph)  It is hard to 
identify S-phase cell accumulation with 3D expression (arrowheads) 
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On the other hand, when you want to check the cell viability, you had better stain with 
Fluorescein diacetate (FDA). Like these examples, when it identifies specifically the 
relationship between cell cycles and cell distributions, this technique is inducted. 
Studies and results about each antineoplastic agents. 
Summary of our results are below. 
1. PGJ2 blocks cell cycle at G0G1. 
2. IFN 、ACNU 、CDDP、As2O3 、TMZ block cell cycle at S phase. 
3. ACNU、CDDP、As2O3、TMZ blocks at G2M phase. 
7.3.1 Prostaglandin J2α(PGJ2α) 
We tried to analyze the mechanism of PGJ2α with FCM after addition for PGJ2͉ to tumor 
cells(Fig8). The cells distribution in S phase are disappeared after addition for PGJ2͉ to 
tumor cells. In other words, cells accumulate in G0G1phase and G2M phase. So PG is 
effective to G0G1 phase. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Left graph is control. Right graph is in case of add PG. Cells in S phase are disappear and cells 
accumulate in G0G1, G2M phase. Results from the above, we thought, PGJ2ǂ effect for GoG1 phase. 
Fig. 8. Reveals dotgram meaning the mechanism of PGJ2ǂ’s antineoplastic effect. 
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7.3.2 Interferon (IFN) 
In the case of IFN, after we added each ͉,͊,͋ IFN(low〜high dose like 102〜105IU/ml) to 
U373MG(105/dish), counted cells on 1st ,3rd,5th day. Results of that, we studied the 
suppression effect of propagate. When studied the graph about cell count after addition of 
IFN ͉,͊,͋ as figure 9, we can observe the suppression of cell count depending on the IFN 
concentration . 
 
 
Fig. 9. Graphs from left to right reveal graph of ǂ,ǃ,Ǆ. Concentrations are heighen increasing 
from upper to lower. The drug having the biggest subtraction from control was IFN ǃwhich 
had the highest suppression of propagation. IFN ǂ had second suppression of propagation. 
In this experiment, IFN Ǆ has not almost suppression of propagation. 
 
 
Fig. 10. Upper row is control. Lower row is histograms of IFNǃ. IFNǃ has early S phase 
block earlier than control group. Then, S phase block was clarified on 3rd day. On 5th day, it 
was observed recruitment. 
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The drug having the biggest subtraction from control was IFN ǃwhich had the highest 
suppression of propagation. IFN ǂ had second suppression of propagation. In this 
experiment, IFN Ǆ has not almost suppression of propagation. As a result of this, we studied 
cell kinetics with IFNǃ. After 104IU/ml IFNǃ was added to U373MG(105/dish), we counted 
cells on 1st ,3rd,5th day and analyzed histogram with FCM. These results are like Fig10. 
IFNǃ has early S phase block earlier than control group. Then, S phase block was clarified 
on 3rd day. On 5th day, it was observed recruitment. 
7.3.3 ACNU 
It reveals a DNA histogram resulted from the addition 5μg/ml 、10μg/ml ACNU to 
U251MG cell lines(fig 11). Standard histogram is revealed in the group of control without 
the addition ACNU. The histogram a day after addition 10μg/ml ACNU reveals DNA 
accumulation in S phase meaning S phase block. Moreover, histogram two days after 
addition 5μg/ml ACNU reveals DNA accumulation in G2M phase and these cells were 
dead. So ACNU has effect both S and G2M phase. 
 
 
Fig. 11. Analysis of cell cycle (U-251). Left upper:Standard histogram is revealed in the 
group of control without the addition ACNU.  Right upper:The histogram a day after 
addition 10μg/ml ACNU reveals DNA accumulation in S phase meaning S phase block. 
Left lower: Histogram two days after addition 5μg/ml ACNU reveals DNA accumulation 
in G2M phase and these cells were dead. Right lower: Histogram two days after addition 40
μg/ml ACNU reveals no accumulation meaning recruitment. 
7.3.4 CDDP, CBDCA 
After it contacted KB cells with 2μg/ml thought ED50 for KB cells CBDCA for 24 hours or 
with 0.5μg/ml CDDP for 24 hours, KB cells were rinsed with PBS two times. It continued 
cell culture and analyzed with FCM, in case of CBDCA on 1st, 2nd, 3rd, in case of CDDP on 
1st, 3rd, 5th, 7th day. In addition, it was performed double staining with BrdU and 3D analysis. 
In case of CBDCA, the peak in S phase of cell accumulation on 1st day transferred into the 
peak in G2M phase of cell accumulation on 2nd and 3rd day (fig12).  In case of CDDP, the 
peak in S phase on 1st, 3rd day transferred tended to migrate gradually into G2M phase 
according to the progression like 5th, 7th day (fig13). 
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Fig. 12. 3D expression of Carboplatin reveals the peak in S phase of cell accumulation on 1st 
day transferred into the peak in G2M phase of cell accumulation on 2nd -3rd day. 
 
 
Fig. 13. 3D expression of cisplatin reveals the peak in S phase on 1st, 3rd day transferred 
tended to migrate gradually into G2M phase according to the progression like 5th, 7th day . 
Result from above, CBDCA has effect in S phase and G2M phase. In case of CDDP, it has the 
same tendency. So CDDP has also effect in S phase and G2M phase (*22) 
7.3.5 As2O3 
It analyzed the change depending on passing time after the addition As2O3 to U87MG and 
T98G cell lines with LSC (fig14). 
In case of U87MG, it observed a DNA accumulation tendency in S phase until 24 hours from 
the addition, this peak immigrated into G2M phase from 24 hours to 72 hours and it 
observed slight accumulation in sub G1 phase from 24 hours to 48 hours.  Though the same 
tendency was in case of T98G, this tendency of cell accumulation was slight different from 
U87MG like fig 14. Result from the above, As2O3 has effective in S and G2M phase (*23). 
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Fig. 14. Cellular DNA content frequency histograms demonstrating As2O3-induced changes 
in cell cycle distribution and apoptosis of U87MG(A) and T98G(B) cells.  
7.3.6 Temozolomide(TMZ) 
Each U373MG (human glioma cell line), U87MG (human) and 9L (rat) cell line was divided 
into three groups: a control group, a low-dose temozolomide group [addition,100〜200 μ
g/ml  temozolomide; near ED 50], and an high-dose temozolomide group [addition, 300〜
500μg/ml].   On day 1, temozolomide was added to each cell line. Then, we counted the 
number of cells on days 2,3,4 and 5. In the U87MG line, we counted the number of cells on 
days 8 and 9. Simultaneously, we performed flow cytometric analysis with the double 
staining (7-AAD and BrdU)(fig 15). 
 
 
Fig. 15. This is experimental method about TMZ. Each cell line was divided into three 
groups, control group, low-dose TMZ group, high-dose TMZ group. On Day 1, TMZ was 
added to each cell line. Then, we counted the number of cells on Day 2, 3, 4, and 5. In 
U87MG, we counted the number of cells on Day 8 and 9. Simultaneously, we performed 
flow cytometric analysis with single and double staining methods. 
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7.4 Result 1  
Suppression of cell proliferation with TMZ 
Growth curves of all cell lines showed suppression of cell growth depended on TMZ 
concentration. A 50% cell-killing effect was obtained with 200-500μg/ml TMZ in U373 and 
100-400μg/ml TMZ in U87MG and 9LMG. This concentration is considered the ED50 
(fig16) In the U373MG cell line, a significant decrease(χ square test) in the growth curve 
was observed with 200μg/ml and 500μg/ml TMZ on day5. In the 9-LMG cell line, a 
significant decrease was observed in 100μg/ml and 400μg/ml TMZ after day 3.Tumor 
cells (in all cell lines) to which TMZ was added showed morphologically shrinkage of cell 
processes, ligetening of the nucleus and cell atrophy (fig 17). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 16. Results of cell counts for U373MG and 9LMG. Both cell lines show that the cell 
killing effect depends on dose concentration. 
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Left: normal glioma cells (before TMZ addition)  
Right:Glioma cells after addtion of TMZ show shrinkage of cell processes pale nuclei, and call atrophy 
Fig. 17. Morphological change of U373 cells with hemaatoxylin and eosin (H＆E) stain 
before and after addition of TMZ 
7.5 Result 2 
Analyses of effect of TMZ on cell cycle with FCM: The U373MG cell line had a tendency to 
accumulate in the G0G1 and S phases on day2 though 4. On day 4 in the group with 200μ
g/ml TMZ added, or days 1 through 4 in the group with 500μg/ml TMZ added, we 
observed significant accumulation (fig 18-19). On days 4 though 5, there was a tendency for 
cells to accumulate in the G2M phase. Especially on day 5, for 200μg/ml TMZ and on days 
4 through 5, for 500μg/ml TMZ we observed significant accumulation ( see fig19-1,2 and 
fig 18-3). The 9-L cell line also accumulated in the S phase from days 2 through 3 and then 
accumulated in the G2M phase (see fig 19-3). The U87 MG cell line also accumulated in S 
phase on days 2 through 3, and then accumulation in G2M phase, and finally in sub-G1 
phase on days 8 through 9(see figs 18-5,6) 
Result 3: The dominant morphological changes observed in U87MG were confined to the 
nuclei (fig 20), with positive terminal deoxynucleotidyl transferase-mediated dUTP-biotin 
nick-end labeling (TINEL) staining. These changes suggested apoptosis (*25). 
 
 
Fig. 18-1. Histogram for U373MG shows changing amount of DNA after addition of TMZ. 
By this histogram, we can see the G2M-phase block after S-phase block. In addition, it shows 
clearly that the G2M-phase block depends on TMZ concentration. 
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Fig. 18-2. For U373MG: 3D expression of changing amount of DNA by using TMZ. The 
G2M-phase block after S-phase block is easily seen 
 
 
 
 
 
Fig. 18-3. Histogram for 9L MG shows changing amount of DNA after addition of TMZ. By 
this histogram, we can see the G2- phase block after S-phase block. In addition, it shows 
clearly that the G2M-phase block after S-phase block depends on TMZ concentration. 
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Fig. 18-4. 9LMG: 3D expression of changing amount of DNA by using TMZ. The G2M –
phase block after S-phase block is easily seen. 
 
 
 
 
 
 
 
Fig. 18-5. Histogram for U87MG shows changing amount of DNA after addition of TMZ. 
The sub-G1 phase peak after S-phase block is easily seen.  
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Fig. 18-6. U87MG: 3D expression of changing amount of DNA by using TMZ. The sub-G1 
phase peak after S phase block is easily seen. 
 
 
 
 
 
Fig. 19-1. Amount of DNA in G0G1 phase with U373MG. On day 2 of addition of 500μg/ml 
TMZ, we observed a statistically significant increase of DNA. On days 4 and 5 of addition of 
200 and 500μg/ml TMZ, we observed a statistically significant decrease of DNA. We called 
this pattern left peak. 
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We called this pattern center peak. 
Fig. 19-2. Amount of DNA in S phase with U373MG. On day 2 of addition of 500 μg/ml 
TMZ., We observed a statistically significant decrease of DNA. On day 4 of addition of 
200mg/ml TMZ., we observed a statistically significant increase of DNA. 
 
 
 
 
Fig. 19-3. Amount of DNA in G2M phase with U373MG. On day 2 of addition of 500μg/ml 
TMZ, we observed a statistically significant decrease of DNA. On days 4 and 5 of addition of 
500μg/ml TMZ and 200μg/ml TMZ, we observed statistically significant increase of DNA. 
We called this pattern right peak. 
www.intechopen.com
 Management of CNS Tumors 308 
  
Fig. 20. Apoptotic cells shown by TUNEL stain (left ×600; right×400) 
8. Discussion 
Each antineoplasitic agent has each pharmacological mechanism. The all reasons of tumor 
cell killing weren’t explained from view in cell kinetics. However, because we can imagine 
the strategy of treatment on the basis of cell kinetics about each antineoplastic agent, it is 
truth that information about cell kinetics has important profile. 
For example, as the radiation that was used with various types of antineoplastic agents, it has 
reported the result of analyses from the view of cell kinetics. Though Yokoyama et al reported 
the slight accumulation in G2M phase at 24 hours after low dose radiation like 5Gy, 7Gy, it is 
no subtraction at 48 hours after radiation. We considered this reversible change. But, in case of 
radiation more than 10Gy, this accumulation in G2M phase decreased additionally. We 
considered this tendency irreversible change (*26). Especially, in case of a study about the 
radiation more than 15 Gy, it reported almost complete G2M block our considered. In addition, 
Kubota et al, with HeLa cells, reported the observation of considerable cell accumulation in S 
phase at 5 hours after 10Gy radiation, then, that accumulation in S phase migrated quickly 
G2M phase meaning considerable G2M block (*27).  
As a result of above, low dose radiation made reversible effect and weak cell cycle block, 
and high radiation made irreversible effect, you know, cell cycle block in S phase migrate in 
G2M phase. These results from radiation are similar to the result from drugs like some 
antineoplastic agents having constant clinical effect. In other word, drugs having weak 
clinical effect have reversible tendency and showed partially cell cycle block.  
What is important in analyze experimentally these cell kinetics, set the cell line and the 
concentrations of drugs. If it is same antineoplastic agent, these drugs tend to have different 
results depends on the difference from kind of cell line, drug concentration, addition 
methods. From the view of clinical application, we might have better choice proper how to 
add and proper drugs. 
For example, as my mentioned before, though S phase block was observed in the result from 
the addition only IFN to glioma, such block effect tended to reversible. However, the clinical 
studied effect for glioma cell with using IFN with TMZ is ensured (COG:Japan Clinical 
Oncolgy Group 0911). In the view of cell kinetics, those mechanisms were considered S and 
G2M blocks in radiation, in addition to the synergy effect between temporary S phase block 
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in IFN and S and G2M blocks in TMZ. From now on everyone expects these effects that IFN 
made the sensitivity of TMZ up via p 53 via the suppression of MGMT gene, in the view of 
pharmacology. 
It might be hard to ensure, even if experimentally, clinically and also in view of cost, these 
synergy effects between radiation and antineoplastic agents. However, when we consider 
the combination of therapeutic alternations and additional methods, we concluded that the 
study of cell kinetics with FCM and LSC, one of data considered like these, is very effective. 
9. Abbreviation 
ACNU (nimusutine hydrochloride) ,  
BCNU (1,3-Bis (2-Chloroethyl)-1-Nitrosourea ),  
CCNU(1-(2-chloroethyl)-3-cyclohexyl-l-nitrosourea),  
MCNU,(1-(2-chloroethyl)-3-(trans-4-methylcycloethyl)-1-nitrosourea),  
IFN (Interferon),  
PCZ(Procarbazine),  
VCR(Vincristine),  
TMZ (Temozolomide),  
CDDP(Cisplatin),  
CBDCA(Carboplatin), 
BBB: Blood Brain Barrier, 
APL : acute promyelocytic leukemia 
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